IDA blend - Antiretroviral therapy coverage
Antiretroviral therapy coverage (% of people living with HIV)
Antiretroviral therapy coverage (% of people living with HIV) in IDA blend was 81.95 as of 2020. Its highest value over the past 20 years was 81.95 in 2020, while its lowest value was 0.00 in 2000.
Definition: Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy.
Source: UNAIDS estimates.
See also:
| Year | Value |
|---|---|
| 2000 | 0.00 |
| 2001 | 0.00 |
| 2002 | 0.25 |
| 2003 | 0.53 |
| 2004 | 2.29 |
| 2005 | 4.06 |
| 2006 | 7.68 |
| 2007 | 10.68 |
| 2008 | 15.16 |
| 2009 | 20.66 |
| 2010 | 26.33 |
| 2011 | 32.47 |
| 2012 | 37.62 |
| 2013 | 42.57 |
| 2014 | 48.35 |
| 2015 | 54.10 |
| 2016 | 60.37 |
| 2017 | 66.21 |
| 2018 | 65.67 |
| 2019 | 72.85 |
| 2020 | 81.95 |
Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)
Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV) in IDA blend was 71.94 as of 2019. Its highest value over the past 19 years was 79.49 in 2016, while its lowest value was 0.00 in 2000.
Definition: Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).
Source: UNAIDS estimates.
See also:
| Year | Value |
|---|---|
| 2000 | 0.00 |
| 2001 | 0.00 |
| 2002 | 1.03 |
| 2003 | 3.39 |
| 2004 | 4.65 |
| 2005 | 11.47 |
| 2006 | 23.15 |
| 2007 | 34.01 |
| 2008 | 46.46 |
| 2009 | 49.81 |
| 2010 | 38.19 |
| 2011 | 52.05 |
| 2012 | 59.30 |
| 2013 | 66.43 |
| 2014 | 74.33 |
| 2015 | 77.96 |
| 2016 | 79.49 |
| 2017 | 76.19 |
| 2018 | 74.59 |
| 2019 | 71.94 |
Classification
Topic: Health Indicators
Sub-Topic: Risk factors
